June 11, 2024 — The Society of Nuclear Medicine and Molecular Imaging recognized six new SNMMI Fellows during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” As the first amyloid-specific and pan-amyloid binding radiotracer designed for planar and SPECT/CT imaging, 99mTc-p5+14 could play an important role in early detection and treatment of cardiac amyloidosis.

June 11, 2024 — A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the potential to spur advances in the treatment of many brain diseases.

June 10, 2024 — Jean-Luc C. Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. 

June 10, 2024 — Carolyn J. Anderson, PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a high-performance, energy-efficient positron emission tomography/computed tomography (PET/CT) scanner with a wide range of clinical capabilities and a low lifetime operational cost. 

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization, showcased cutting-edge breast cancer research aimed at advancing the field at the ASCO Annual Meeting 2024. Organized by the American Society of Clinical Oncology, this premier conference annually convenes over 40,000 oncologists and stakeholders worldwide. 

June 6, 2024 — Sunway Medical Centre, Sunway City (SMC), the largest private quaternary hospital in Malaysia, embarks on a transformative journey in healthcare delivery through its partnership with Annalise.ai, a leading provider of artificial intelligence (AI) solutions in radiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now